Lisa Swift, APRN
Adult Health · Tucker, GANPI 1982803995
Payments from drug & device makers
Across 100 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$248
- AbbVie$179
- Biogen$136
- AstraZeneca$134
- Amgen$124
- Novo Nordisk$99
- plus $953 from 23 others
What the payments were for
- Food & beverage$1,77395%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $248 |
| AbbVie | 10 | $179 |
| Biogen | 6 | $136 |
| AstraZeneca | 9 | $134 |
| Amgen | 6 | $124 |
| Novo Nordisk | 6 | $99 |
| Lilly USA, LLC | 7 | $99 |
| GSK | 5 | $90 |
| Bayer | 4 | $84 |
| Exact Sciences | 4 | $73 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Corcept Therapeutics | 3 | $62 |
| Mylan Specialty L.p. | 3 | $57 |
| Inspire Medical Systems, Inc. | 1 | $52 |
| Johnson & Johnson | 3 | $48 |
| Dexcom, Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $22 |
| Abbott | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Mannkind Corporation | 1 | $12 |
How this compares
$1,873 in reported general payments places this provider in the 75th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $12,323 |
| EliquisApixaban | 11 | $12,224 |
| OzempicSemaglutide | 11 | $10,541 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,303 |
| Gabapentin | 54 | $848 |
| Omeprazole | 37 | $792 |
| Famotidine | 24 | $659 |
| Pregabalin | 23 | $599 |
| Memantine Hcl | 21 | $504 |
| Fluticasone Propionate | 43 | $498 |
| Losartan Potassium | 46 | $496 |
| Levothyroxine Sodium | 39 | $466 |
| Mirtazapine | 18 | $405 |
| Metoprolol Succinate | 28 | $376 |
| Methylprednisolone | 52 | $374 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $90 | $12,32315 claims |
| PfizerEliquis | $17 | $12,22411 claims |
| Novo NordiskOzempic | $99 | $10,54111 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $46639 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 577 adult health providers in Georgia.
Other adult health in Tucker
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
- Jennifer SheldonMacon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.